PB2129: THE MODAKAFUSP ALFA IINNOVATE CLINICAL DEVELOPMENT PROGRAM: RATIONALE AND DESIGN OF 3 PHASE 1/2 TRIALS OF AN INNATE IMMUNITY ENHANCER FOR MULTIPLE MYELOMA (MM)

Detalles Bibliográficos
Autores principales: Holstein, Sarah A., Mian, Hira, Touzeau, Cyrille, Kingsley, Edwin, Vogl, Dan, Zuniga, Richard, Suryanarayan, Kaveri, Wang, Shining, Thesillat-Versmee, Laura, Liu, Yuyin, Chen, Tian, Zhang, Yefei, Parot, Xavier, Lee, Hans C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429291/
http://dx.doi.org/10.1097/01.HS9.0000975280.98608.35

Ejemplares similares

Ejemplares similares